Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “mRNA Vaccination”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Enrolling By InvitationNCT07330440
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination

Who this might be right for
Genital Herpes
Changchun BCHT Biotechnology Co. 144
Post-approval studies (Phase 4)UnknownNCT04978038
What this trial is testing

Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs

Who this might be right for
SARS-CoV2 InfectionCoronavirus Infection
Mark Loeb 414
Not applicableStudy completedNCT05894590
What this trial is testing

Post-Marketing Non-Acute Safety Study in Japan After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons at High Risk of Severe COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 13,680
Testing effectiveness (Phase 2)Study completedNCT05553301
What this trial is testing

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 560
Testing effectiveness (Phase 2)WithdrawnNCT05465902
What this trial is testing

Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster

Who this might be right for
COVID-19SARS-CoV-2 Infection
WestVac Biopharma Co., Ltd.
Large-scale testing (Phase 3)WithdrawnNCT04848467
What this trial is testing

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

Who this might be right for
SARS-CoV-2 InfectionCoronavirus Disease 2019 (COVID-19)
Bayer
Testing effectiveness (Phase 2)Active Not RecruitingNCT06907511
What this trial is testing

Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and Older

Who this might be right for
Pandemic Influenza ImmunizationHealthy Volunteers
Sanofi 720
Testing effectiveness (Phase 2)Study completedNCT05077254
What this trial is testing

COVID Protection After Transplant-Immunosuppression Reduction

Who this might be right for
Kidney Transplant RecipientsLiver Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 48
Large-scale testing (Phase 3)UnknownNCT05382871
What this trial is testing

Sequential Immunization of Two Doses of Inactivated COVID-19 Vaccine (Omicron) in Vaccinated Population Aged 18 Years and Above

Who this might be right for
COVID-19
China National Biotec Group Company Limited 1,804
Testing effectiveness (Phase 2)UnknownNCT05939648
What this trial is testing

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)

Who this might be right for
SARS-CoV-2
AIM Vaccine Co., Ltd. 450
Not applicableUnknownNCT05186571
What this trial is testing

Myopericarditis After Messenger Ribonucleic Acid (mRNA) COVID-19 Vaccination in Children 5-11 Years Old

Who this might be right for
MyopericarditisMyocarditisVaccination; Complications+2 more
Rigshospitalet, Denmark 350,000
Early research (Phase 1)Study completedNCT00834002
What this trial is testing

Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in Remission

Who this might be right for
Acute Myeloid Leukemia (AML)
University Hospital, Antwerp 10
Large-scale testing (Phase 3)UnknownNCT05580159
What this trial is testing

New Generation mRNA Booster Vaccine Against Emerging VOCs

Who this might be right for
ImmunogenicityEfficacySafety
Stemirna Therapeutics 2,000
Testing effectiveness (Phase 2)Study completedNCT01291420
What this trial is testing

Dendritic Cell Vaccination for Patients with Solid Tumors

Who this might be right for
GlioblastomaRenal Cell CarcinomaSarcomas+3 more
University Hospital, Antwerp 48
Not applicableStudy completedNCT05475067
What this trial is testing

Fever Tracking Study

Who this might be right for
Core Body Temperature in Healthy SubjectsImmune Response to mRNA COVID-19 Vaccination
University Hospital, Basel, Switzerland 61
Post-approval studies (Phase 4)Study completedNCT06503900
What this trial is testing

Simultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy Study

Who this might be right for
Birth OutcomesSafetyAdverse Event Following Immunization
Duke University 98
Not applicableActive Not RecruitingNCT04880174
What this trial is testing

SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination

Who this might be right for
SARS-CoV Infection
Universitair Ziekenhuis Brussel 500
Post-approval studies (Phase 4)Ended earlyNCT05075538
What this trial is testing

COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2

Who this might be right for
Cancer
Jules Bordet Institute 152
Post-approval studies (Phase 4)Study completedNCT05168709
What this trial is testing

Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction

Who this might be right for
COVID-19Vaccine ReactionImmunization; Infection
Murdoch Childrens Research Institute 51
Post-approval studies (Phase 4)UnknownNCT06587503
What this trial is testing

Safety and Immunogenicity of rVSVΔG-ZEBOV-GP Vaccination When Dosed Concurrently With mRNA COVID-19 Vaccine Booster Doses

Who this might be right for
Ebola Virus DiseaseCOVID-19
University of Birmingham 72
Next Page